Sinopharm Holdings and Novartis China Launch Strategic Collaboration Upgrade Focused on Value-Based Retail and Patient-Centric Health Services

Recently, Sinopharm Group and Novartis China officially embarked on a new journey of strategic cooperation upgrade in Shanghai, with the core concept of "Value Retail: Born for Patients." This collaboration will focus on enhancing the professional service capabilities of pharmacists and fully promoting the transformation and upgrading of retail pharmacies into "health solution service providers."

As people's health awareness continues to improve, the role of retail pharmacies has undergone profound changes. Patients' demand for health services is no longer limited to traditional drug supply but rather a growing desire for professional health advisory services. Against this backdrop, the upgraded cooperation between Sinopharm Group Co., Ltd. and Novartis China aims to better meet this ever-evolving market demand.

In this upgraded collaboration, enhancing the professional service capabilities of pharmacists is undoubtedly one of the core tasks. Both parties will leverage their respective advantageous resources to provide pharmacists with comprehensive and systematic professional training and support, helping them achieve significant improvements in disease area knowledge, pharmaceutical service skills, and pharmacy management.

In fact, Wang Junxing, head of Novartis China's retail division, pointed out that over the past five years, Novartis and Sinopharm Group Co., Ltd. have engaged in in-depth cooperation. In disease areas such as hypertension and immunology, they have successfully trained and empowered more than a hundred "gold-medal pharmacists," providing patients with high-quality full-course disease management services, allowing innovative treatment solutions to benefit more patients. This upgraded collaboration will further expand the scale of professional pharmacist training, improve training quality, and provide solid talent support for the transformation and upgrading of retail pharmacies.

In order to promote the transformation and upgrading of retail pharmacies into "health solution service providers," Sinopharm Group Co., Ltd., with the support of Novartis, has officially launched the "Sinopharm Cardiovascular Health Service Center." The project will adopt a dual-driven model of "professional service foundation + innovative service empowerment," aiming to build a full-cycle health service system covering multiple aspects such as disease education and medication management.

Through this innovative model, both parties will jointly explore a replicable and scalable path for the transformation and upgrading of retail pharmacies, creating a more convenient, efficient, and professional health service closed loop for patients. This will not only help improve the medical experience and health outcomes of patients but also provide valuable insights for the innovative development of the entire pharmaceutical retail industry.

Conclusion: The strategic cooperation upgrade between Sinopharm Group Co.,Ltd. and Novartis China marks a solid step forward in promoting the transformation and development of the pharmaceutical retail industry. By enhancing the professional service capabilities of pharmacists and building a full-cycle health service system, retail pharmacies will gradually achieve a transformation and upgrading from traditional drug sales to professional health services, providing patients with higher quality and more efficient health solutions.

Reference Source:

1.https://www.sinopharmgroup.com.cn/gykg/xwzx/gsxw/2025/6/I1379763523852173312.html

2.https://mp.weixin.qq.com/s/L_fug-JsBX6HgH5dwtawMQ

Editorial Responsibility: Liuli

Disclaimer: The views expressed in this article are solely those of the author and do not represent the position of Pharma Intelligence. We welcome discussions and additional insights in the comment section; for reprints, please be sure to credit the author and source. If there are any issues regarding the content, copyright, or other aspects of the article, please leave a message on this platform, and we will address it promptly.